ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

BDTX Black Diamond Therapeutics Inc

5,10
-0,22 (-4,14%)
21 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Black Diamond Therapeutics Inc BDTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,22 -4,14% 5,10 01:46:14
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,37 4,94 5,37 4,98 5,32
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/6/202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:06EDGAR2Form 8-K - Current report
01/6/202416:00GLOBEBlack Diamond Therapeutics Presents Promising BDTX-1535..
29/5/202414:00GLOBEBlack Diamond Therapeutics to Participate in Jefferies..
14/5/202401:09EDGAR2Form SC 13D/A - General statement of acquisition of..
09/5/202413:30GLOBEBlack Diamond Therapeutics Reports First Quarter 2024..
09/5/202413:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:10EDGAR2Form 8-K - Current report
24/4/202422:05GLOBEBlack Diamond Therapeutics Announces Presentations at the..
11/4/202414:00GLOBEBlack Diamond Therapeutics Announces Changes to Board of..
08/4/202400:00GLOBEBlack Diamond Therapeutics Presents Novel Real-World..
03/4/202414:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
12/3/202413:00GLOBEBlack Diamond Therapeutics Reports Fourth Quarter and Full..
11/3/202418:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/3/202422:30GLOBEBlack Diamond Therapeutics Announces Upcoming Presentation..
28/2/202414:00GLOBEBlack Diamond Therapeutics to Participate in the TD Cowen..
15/2/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:04EDGAR2Form 8-K - Current report
04/1/202414:07EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEBlack Diamond Therapeutics Announces Corporate Update and..
13/12/202313:08EDGAR2Form 8-K - Current report
13/12/202313:00GLOBEBlack Diamond Therapeutics Announces Topline Results from..
07/11/202314:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
06/11/202313:45GLOBEBlack Diamond Therapeutics Reports Third Quarter 2023..
06/11/202313:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202313:10EDGAR2Form 8-K - Current report
14/10/202318:30GLOBEBlack Diamond Therapeutics Presents Dose Escalation Data..
04/10/202318:14GLOBEBlack Diamond Therapeutics to Present Preclinical and..
18/9/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202313:12EDGAR2Form 8-K - Current report
18/9/202313:00GLOBEBlack Diamond Therapeutics Announces CEO Transition
11/9/202314:00GLOBEBlack Diamond Therapeutics Announces First Patients Dosed in..
05/9/202314:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
11/8/202313:30GLOBEBlack Diamond Therapeutics Reports Second Quarter 2023..
11/8/202313:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202313:22EDGAR2Form 8-K - Current report
30/6/202322:03EDGAR2Form 8-K - Current report
30/6/202322:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/6/202302:57GLOBEBlack Diamond Therapeutics Announces Pricing of Public..
29/6/202312:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202322:23GLOBEBlack Diamond Therapeutics Announces Proposed Public..
27/6/202313:00GLOBEBlack Diamond Therapeutics Announces Initial Dose Escalation..

Dernières Valeurs Consultées

Delayed Upgrade Clock